- Trials with a EudraCT protocol (167)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
167 result(s) found for: Nutritional Disorder.
Displaying page 1 of 9.
EudraCT Number: 2008-000330-50 | Sponsor Protocol Number: EC07/90285 | Start Date*: 2008-10-27 | |||||||||||
Sponsor Name:Organisation name was not entered | |||||||||||||
Full Title: EFECTO DE SUPLEMENTACIÓN NUTRICIONAL ENRIQUECIDA CON ÁCIDOS GRASOS OMEGA-3 EN EL ESTRÉS OXIDATIVO Y METABOLISMO LIPÍDICO DE PACIENTES CON PROCESOS ONCOLÓGICOS DEL ÁREA OTORRINOLARINGOLÓGICA (ORL) ... | |||||||||||||
Medical condition: Determinar las modificaciones inducidas por la suplementación especifica de ácidos grasos omega3 en el estrés oxidativo y estado inflamatorio en pacientes oncológicos sometidos a tratamiento radiot... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000215-32 | Sponsor Protocol Number: Pycno2015-14 | Start Date*: 2016-10-04 | ||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:University of Antwerp | ||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Effect of Pycnogenol® on Attention-Deficit Hyperactivity Disorder (ADHD): A randomized, double blind, placebo and active product controlled multicenter trial. | ||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Attention-deficit hyperactivity disorder (ADHD) | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: BE (Prematurely Ended) | ||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-005107-33 | Sponsor Protocol Number: 25659 | Start Date*: 2012-01-13 | |||||||||||
Sponsor Name:AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA | |||||||||||||
Full Title: dietary nutritional counseling or phosphate binders in the early stages of chronic kidney disease: effects on FGF 23 | |||||||||||||
Medical condition: chronic kidney failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002318-15 | Sponsor Protocol Number: 010921 | Start Date*: 2021-09-15 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Copenhagen University Hospital, Amager and Hvidovre, Department of Clinical Research | ||||||||||||||||||||||||||||||||||||||
Full Title: A pharmacological trial with Sativex® and gentamicin for optimized pharmacological treatment of older patients with a focus on appetite stimulation and renal risk drugs | ||||||||||||||||||||||||||||||||||||||
Medical condition: | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: DK (Ongoing) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005719-89 | Sponsor Protocol Number: 12440 / R-0631M / Melody | Start Date*: 2007-01-04 | |||||||||||
Sponsor Name:Meander Medical Center | |||||||||||||
Full Title: Double blind placebo controlled study on the efficacy of melatonin on sleep parameters and quality of life in hemodialysis patients | |||||||||||||
Medical condition: Sleep problems in hemodialysis patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-015875-28 | Sponsor Protocol Number: CF002 | Start Date*: 2009-10-07 | ||||||||||||||||
Sponsor Name:UNIVERSITA` DEGLI STUDI DI NAPOLI FEDERICO II | ||||||||||||||||||
Full Title: Modulation of intestinal and extraintestinal inflammation in infants with Cystic Fibrosis by early modification of intestinal microflora | ||||||||||||||||||
Medical condition: infants with cystic fibrosis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000565-40 | Sponsor Protocol Number: GLM101-002 | Start Date*: 2022-11-04 | |||||||||||
Sponsor Name:Glycomine, Inc | |||||||||||||
Full Title: A Phase 2, Randomized, Open-Label, 12-Week Study to Assess the Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of GLM101 Administered Intravenously to Adult Participa... | |||||||||||||
Medical condition: PMM2-CDG | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011289-27 | Sponsor Protocol Number: CF001 | Start Date*: 2009-04-22 | |||||||||||
Sponsor Name:UNIVERSITA` DEGLI STUDI DI NAPOLI FEDERICO II | |||||||||||||
Full Title: Probiotics in Cystic Fibrosis | |||||||||||||
Medical condition: Cystic Fibrosis Patients | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004951-35 | Sponsor Protocol Number: DISOBBED-12 | Start Date*: 2013-01-18 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERO UNIVERSITARIA DI CAGLIARI | |||||||||||||
Full Title: Disulfiram, obesity and binge eating disorder | |||||||||||||
Medical condition: Obesity and binge eating disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002096-26 | Sponsor Protocol Number: MV-3-2017 | Start Date*: 2017-08-24 | ||||||||||||||||||||||||||
Sponsor Name:Universitetsklinik for Nyresygdomme og Blodtryksforhøjelse, Regionshospitalet Holstebro; Hospitalsenheden Vest | ||||||||||||||||||||||||||||
Full Title: Investigate the differences between treating Chronic Kidney Disease - Mineral and Bone Disorder with an iron-containing phosphate binder or a calcium-containing phosphate binder in dialysis patients. | ||||||||||||||||||||||||||||
Medical condition: Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD), especially bone metabolism and blood vessel calcification | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-003214-41 | Sponsor Protocol Number: NEF-DIU-2013 | Start Date*: 2013-11-11 | |||||||||||
Sponsor Name:Fundació Parc Taulí | |||||||||||||
Full Title: Single center randomized clinical study to compare the efficacy of diuretics in patients in hemodialysis with residual renal function | |||||||||||||
Medical condition: Chronic renal disease stage V in hemodialysis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002472-16 | Sponsor Protocol Number: CCD09 | Start Date*: 2011-12-19 | |||||||||||
Sponsor Name:Cytonet GmbH & Co KG | |||||||||||||
Full Title: Open, prospective, diagnostic, multicentre study in healthy subjects, patients with urea cycle disorders (UCD), and carriers of UCD mutations, to evaluate in vivo ureagenesis measured after a singl... | |||||||||||||
Medical condition: 1. Healthy subjects 2. Symptomatic UCD patients with genetically confirmed CPSD, OTCD, ASSD, or ASLD 3. Asymptomatic carriers of UCD mutations (e.g. parents) | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005330-12 | Sponsor Protocol Number: RAA06-003 | Start Date*: 2006-05-11 |
Sponsor Name:King's College London (IOP) | ||
Full Title: Omega-3 Fatty Acids Supplementation for Adolescent Boys with Attention Deficit Hyperactivity Disorder : a double-blind, randomized controlled trial | ||
Medical condition: Attention deficit / hyperactivity disorder (ADHD) is defined by DSM-IV criteria, which shows inattention, hyperactivity and impulsivity. ADHD is one of the most common child psychiatric disorders,... | ||
Disease: | ||
Population Age: Adolescents, Under 18 | Gender: Male | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-022677-34 | Sponsor Protocol Number: EMR200109-619 | Start Date*: 2011-09-07 | ||||||||||||||||
Sponsor Name:Dekan des Fachbereichs Humanmedizin | ||||||||||||||||||
Full Title: Influence of high dose vitamin D substitution on humoral immunity and lymphocyte function in patients with type 1 diabetes mellitus or Addison´s disease (ViDDA1) | ||||||||||||||||||
Medical condition: Type 1 diabetes mellitus or Addison´s disease (ViDDA1) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-004854-29 | Sponsor Protocol Number: S245.4.008 | Start Date*: 2007-09-21 | |||||||||||
Sponsor Name:Abbott Products GmbH | |||||||||||||
Full Title: One week double-blind, randomized, placebo-controlled, parallel-group, multi-center study with Creon® 25000 Minimicrospheres™ in subjects with pancreatic exocrine insufficiency after pancreatic sur... | |||||||||||||
Medical condition: Pancreatic Exocrine Insufficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) IT (Completed) BG (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001550-34 | Sponsor Protocol Number: TIGEM2-PDH | Start Date*: Information not available in EudraCT | |||||||||||||||||||||||||||||||
Sponsor Name:FONDAZIONE TELETHON | |||||||||||||||||||||||||||||||||
Full Title: Studio clinico pilota per valutare l’efficacia della terapia con fenilbutirrato in pazienti affetti da deficit di piruvato deidrogenasi | |||||||||||||||||||||||||||||||||
Medical condition: La Sperimentazione verrà eseguita su pazienti affetti da difetto dell’enzima piruvato deidrogenasi.I pazienti affetti da questa malattia manifestano aumento dei livelli di lattato nel sangue e nell... | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002984-24 | Sponsor Protocol Number: PHS-Px-104-II-01 | Start Date*: 2013-10-07 | |||||||||||
Sponsor Name:Phenex Pharmaceuticals AG | |||||||||||||
Full Title: A Safety Pilot Study of Px-104 in non alcoholic fatty liver disease (NAFLD) patients | |||||||||||||
Medical condition: Non-alcoholic fatty liver disease (NAFLD) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-000933-18 | Sponsor Protocol Number: HLSC-UCD-02 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Unicyte AG | |||||||||||||
Full Title: An Open-label, Non-controlled, Multi-center, Phase 2 Study to Assess the Efficacy and Safety of Allogeneic Human Liver Stem Cells (HLSCs) in the Treatment of Pediatric Patients with Early-onset Ure... | |||||||||||||
Medical condition: Urea cycle disorders | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002674-36 | Sponsor Protocol Number: 49929 | Start Date*: 2017-10-12 |
Sponsor Name: | ||
Full Title: DOES ARGININE ENHANCE GALACTOSE OXIDATIVE CAPACITY IN CLASSIC GALACTOSEMIA? A PILOT STUDY | ||
Medical condition: Classic galactosemia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2011-002823-16 | Sponsor Protocol Number: 02-2011 | Start Date*: 2011-07-27 | |||||||||||
Sponsor Name:A.O. UNIVERSITARIA INTEGRATA DI VERONA | |||||||||||||
Full Title: Effects of Vitamin D in patients affected by heart failure | |||||||||||||
Medical condition: Heart failure is a condition that occurs when the heart loses its normal ability to pump blood to maintain vital body functions and, therefore, works with lower efficiency. Several studies have sho... | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.